Previous study revealed that AIM2 inflammasome in HCC cells suppressed mammalian target of rapamycin (mTOR)‐S6K1 pathway,28 and suggested that mTOR pathway might be involved in AIM2‐induced downstream pathway. The gene discussed is RPS6KB1; the disease is hepatocellular carcinoma.